Vitreomacular adhesion patients report improved vision with non-surgical treatment

In two ancillary studies of two multi-center international clinical trials, the injectable drug ocriplasmin appears to improve vision among patients suffering from symptomatic vitreomacular adhesion (VMA), a condition related to the aging eye that could cause permanent vision loss if left untreated.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1HTzi3d